Table 7.

Suggestions regarding abrocitinib dosing due to hematologic aberrations[52]

Laboratory Measure	Recommendation
Platelet Count <50000/mm3	Discontinue abrocitinib and follow with CBC until >100,000/mm3
ALC <500/mm3	Treatment should be temporarily discontinued if ALC is less than 500 cells/mm3 and may be restarted once ALC returns above this value
ANC <1000/mm3	Treatment should be temporarily discontinued if ANC is less than 1000 cells/mm3 and may be restarted once ANC returns above this value
Hb value <8 g/dL	Treatment should be temporarily discontinued if Hb is less than 8 g/dL and may be restarted once Hb returns above this value

Hb=Hemoglobin, ALC=Absolute lymphocyte count, ANC=Absolute neutrophil count